T. Rowe Price Associates’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-209,418
| Closed | -$186K | – | 2992 |
|
2022
Q4 | $186K | Buy |
209,418
+16,181
| +8% | +$14.4K | ﹤0.01% | 2553 |
|
2022
Q3 | $304K | Buy |
193,237
+51,676
| +37% | +$81.3K | ﹤0.01% | 2375 |
|
2022
Q2 | $285K | Buy |
141,561
+10,846
| +8% | +$21.8K | ﹤0.01% | 2457 |
|
2022
Q1 | $305K | Buy |
130,715
+18,809
| +17% | +$43.9K | ﹤0.01% | 2535 |
|
2021
Q4 | $520K | Buy |
111,906
+9,933
| +10% | +$46.2K | ﹤0.01% | 2370 |
|
2021
Q3 | $778K | Sell |
101,973
-22,500
| -18% | -$172K | ﹤0.01% | 2164 |
|
2021
Q2 | $1.21M | Buy |
124,473
+13,989
| +13% | +$136K | ﹤0.01% | 1986 |
|
2021
Q1 | $914K | Sell |
110,484
-7,891
| -7% | -$65.3K | ﹤0.01% | 2095 |
|
2020
Q4 | $808K | Buy |
118,375
+4,222
| +4% | +$28.8K | ﹤0.01% | 2037 |
|
2020
Q3 | $1.27M | Buy |
114,153
+41,607
| +57% | +$464K | ﹤0.01% | 1704 |
|
2020
Q2 | $456K | Sell |
72,546
-3,643
| -5% | -$22.9K | ﹤0.01% | 2084 |
|
2020
Q1 | $140K | Buy |
76,189
+32,000
| +72% | +$58.8K | ﹤0.01% | 2368 |
|
2019
Q4 | $149K | Buy |
44,189
+4,864
| +12% | +$16.4K | ﹤0.01% | 2424 |
|
2019
Q3 | $84K | Buy |
39,325
+953
| +2% | +$2.04K | ﹤0.01% | 2456 |
|
2019
Q2 | $102K | Buy |
38,372
+25,200
| +191% | +$67K | ﹤0.01% | 2468 |
|
2019
Q1 | $63K | Buy |
13,172
+400
| +3% | +$1.91K | ﹤0.01% | 2486 |
|
2018
Q4 | $31K | Sell |
12,772
-60,454
| -83% | -$147K | ﹤0.01% | 2527 |
|
2018
Q3 | $322K | Buy |
73,226
+24,653
| +51% | +$108K | ﹤0.01% | 2322 |
|
2018
Q2 | $350K | Buy |
48,573
+3,877
| +9% | +$27.9K | ﹤0.01% | 2288 |
|
2018
Q1 | $230K | Sell |
44,696
-32,604
| -42% | -$168K | ﹤0.01% | 2361 |
|
2017
Q4 | $294K | Buy |
+77,300
| New | +$294K | ﹤0.01% | 2273 |
|
2015
Q4 | – | Sell |
-30,462
| Closed | -$256K | – | 2548 |
|
2015
Q3 | $256K | Buy |
+30,462
| New | +$256K | ﹤0.01% | 2197 |
|